Serum lipids in primary sclerosing cholangitis

Digestive and Liver Disease

Volumn 44, Issue 1, 2012, Pages 44-48

  Sinakos, Emmanouil ^a   Abbas, Ghulam ^a   Jorgensen, Roberta A ^a   Lindor, Keith D ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Cholestasis; Coronary artery disease; Dyslipidemia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLANGITIS, SCLEROSING; CHOLESTEROL; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TRIGLYCERIDES; URSODEOXYCHOLIC ACID;

EID: 83855165770     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.07.020     Document Type: Article

References (21)

1. Lee Y.M., Kaplan M.M. Primary sclerosing cholangitis. N Engl J Med 1995, 332:924-933.
2. Jorgensen R.A., Lindor K.D., Sartin J.S., et al. Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. J Clin Gastroenterol 1995, 20:215-219.
3. Gandelman G., Aronow W.S., Weiss M.B. Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis. Am J Ther 2006, 13:171-174.
4. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
5. Allocca M., Crosignani A., Gritti A., et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 2006, 55:1795-1800.
6. Crippin J.S., Lindor K.D., Jorgensen R., et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?. Hepatology 1992, 15:858-862.
7. Longo M., Crosignani A., Battezzati P.M., et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002, 51:265-269.
8. Kowdley K.V. Lipids and lipid-activated vitamins in chronic cholestatic diseases. Clin Liver Dis 1998, 2:373-389.
9. Harnois D.M., Angulo P., Jorgensen R.A., et al. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001, 96:1558-1562.
10. Lindor K.D. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997, 336:691-695.
11. Lindor K.D., Kowdley K.V., Luketic V.A., et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009, 50:808-814.
12. Lloyd-Jones D.M., Larson M.G., Beiser A., et al. Lifetime risk of developing coronary heart disease. Lancet 1999, 353:89-92.
13. Getz L., Kirkengen A.L., Hetlevik I., et al. Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study. Scand J Prim Health Care 2004, 22:202-208.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) J Am Med Assoc 2001, 285:2486-2497.
15. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002, 106:3143-3421.
16. Gylling H., Farkkila M., Vuoristo M., et al. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics. Hepatology 1995, 21:89-95.
17. Jahn C.E., Schaefer E.J., Taam L.A., et al. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology 1985, 89:1266-1278.
18. Chang P.Y., Lu S.C., Su T.C., et al. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res 2004, 45:2116-2122.
19. Su T-C., Hwang J-J., Kao J-H., et al. Hypercholesterolemia in primary biliary cirrhosis. N Engl J Med 2007, 357:1561-1562.
20. Floreani A., Variola A., Niro G., et al. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol 2008, 103:1959-1965.
21. Balan V., Dickson E.R., Jorgensen R.A., et al. Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. Mayo Clin Proc 1994, 69:923-929.